Protein Tyrosine Kinase 6 Directly Phosphorylates AKT and Promotes AKT Activation in Response to Epidermal Growth Factor

REFERENCES

• Alessi, D. R., M. Andjelkovic, B. Caudwell, P. Cron, N. Morrice, P. Cohen, and B. A. Hemmings. 1996. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15:6541–6551.
   PubMed Web of Science ®Google Scholar
• Altomare, D. A., H. You, G. H. Xiao, M. E. Ramos-Nino, K. L. Skele, A. De Rienzo, S. C. Jhanwar, B. T. Mossman, A. B. Kane, and J. R. Testa. 2005. Human and mouse mesotheliomas exhibit elevated AKT/PKB activity, which can be targeted pharmacologically to inhibit tumor cell growth. Oncogene 24:6080–6089.
   PubMed Web of Science ®Google Scholar
• Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389–3402.
   PubMed Web of Science ®Google Scholar
• Aubele, M., G. Auer, A. K. Walch, A. Munro, M. J. Atkinson, H. Braselmann, T. Fornander, and J. M. Bartlett. 2007. PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas. Br. J. Cancer 96:801–807.
   PubMed Web of Science ®Google Scholar
• Aubele, M., A. K. Walch, N. Ludyga, H. Braselmann, M. J. Atkinson, B. Luber, G. Auer, S. Tapio, T. Cooke, and J. M. Bartlett. 2008. Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients. Br. J. Cancer 99:1089–1095.
   PubMedGoogle Scholar
• Barker, K. T., L. E. Jackson, and M. R. Crompton. 1997. BRK tyrosine kinase expression in a high proportion of human breast carcinomas. Oncogene 15:799–805.
   PubMed Web of Science ®Google Scholar
• Bellacosa, A., C. C. Kumar, A. Di Cristofano, and J. R. Testa. 2005. Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv. Cancer Res. 94:29–86.
   PubMed Web of Science ®Google Scholar
• Born, M., L. Quintanilla-Fend, H. Braselmann, U. Reich, M. Richter, P. Hutzler, and M. Aubele. 2005. Simultaneous over-expression of the Her2/neu and PTK6 tyrosine kinases in archival invasive ductal breast carcinomas. J. Pathol. 205:592–596.
   PubMed Web of Science ®Google Scholar
• Brauer, P. M., and A. L. Tyner. 2010. Building a better understanding of the intracellular tyrosine kinase PTK6—BRK by BRK. Biochim. Biophys. Acta 1806:66–73.
   PubMed Web of Science ®Google Scholar
• Chen, H. Y., C. H. Shen, Y. T. Tsai, F. C. Lin, Y. P. Huang, and R. H. Chen. 2004. Brk activates Rac1 and promotes cell migration and invasion by phosphorylating paxillin. Mol. Cell. Biol. 24:10558–10572.
   PubMed Web of Science ®Google Scholar
• Chen, R., O. Kim, J. Yang, K. Sato, K. M. Eisenmann, J. McCarthy, H. Chen, and Y. Qiu. 2001. Regulation of Akt/PKB activation by tyrosine phosphorylation. J. Biol. Chem. 276:31858–31862.
   PubMedGoogle Scholar
• Conus, N. M., K. M. Hannan, B. E. Cristiano, B. A. Hemmings, and R. B. Pearson. 2002. Direct identification of tyrosine 474 as a regulatory phosphorylation site for the Akt protein kinase. J. Biol. Chem. 277:38021–38028.
   PubMed Web of Science ®Google Scholar
• Cui, Q. L., W. H. Zheng, R. Quirion, and G. Almazan. 2005. Inhibition of Src-like kinases reveals Akt-dependent and -independent pathways in insulin-like growth factor I-mediated oligodendrocyte progenitor survival. J. Biol. Chem. 280:8918–8928.
   PubMed Web of Science ®Google Scholar
• Derry, J. J., G. S. Prins, V. Ray, and A. L. Tyner. 2003. Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells. Oncogene 22:4212–4220.
   PubMed Web of Science ®Google Scholar
• Derry, J. J., S. Richard, H. Valderrama Carvajal, X. Ye, V. Vasioukhin, A. W. Cochrane, T. Chen, and A. L. Tyner. 2000. Sik (BRK) phosphorylates Sam68 in the nucleus and negatively regulates its RNA binding ability. Mol. Cell. Biol. 20:6114–6126.
   PubMed Web of Science ®Google Scholar
• Easty, D. J., P. J. Mitchell, K. Patel, V. A. Florenes, R. A. Spritz, and D. C. Bennett. 1997. Loss of expression of receptor tyrosine kinase family genes PTK7 and SEK in metastatic melanoma. Int. J. Cancer 71:1061–1065.
   PubMed Web of Science ®Google Scholar
• El Sheikh, S. S., J. Domin, P. Abel, G. Stamp, and E.-N. Lalani. 2004. Phosphorylation of both EGFR and ErbB2 is a reliable predictor of prostate cancer cell proliferation in response to EGF. Neoplasia 6:846–853.
   PubMedGoogle Scholar
• Eves, E. M., W. Xiong, A. Bellacosa, S. G. Kennedy, P. N. Tsichlis, M. R. Rosner, and N. Hay. 1998. Akt, a target of phosphatidylinositol 3-kinase, inhibits apoptosis in a differentiating neuronal cell line. Mol. Cell. Biol. 18:2143–2152.
   PubMed Web of Science ®Google Scholar
• Gingras, A. C., S. G. Kennedy, M. A. O'Leary, N. Sonenberg, and N. Hay. 1998. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev. 12:502–513.
   PubMed Web of Science ®Google Scholar
• Haegebarth, A., W. Bie, R. Yang, S. E. Crawford, V. Vasioukhin, E. Fuchs, and A. L. Tyner. 2006. Protein tyrosine kinase 6 negatively regulates growth and promotes enterocyte differentiation in the small intestine. Mol. Cell. Biol. 26:4949–4957.
   PubMed Web of Science ®Google Scholar
• Haegebarth, A., A. O. Perekatt, W. Bie, J. J. Gierut, and A. L. Tyner. 2009. Induction of protein tyrosine kinase 6 in mouse intestinal crypt epithelial cells promotes DNA damage-induced apoptosis. Gastroenterology 137:945–954.
   PubMed Web of Science ®Google Scholar
• Harvey, A. J., and M. R. Crompton. 2003. Use of RNA interference to validate Brk as a novel therapeutic target in breast cancer: Brk promotes breast carcinoma cell proliferation. Oncogene 22:5006–5010.
   PubMed Web of Science ®Google Scholar
• Hayward, S. W., R. Dahiya, G. R. Cunha, J. Bartek, N. Deshpande, and P. Narayan. 1995. Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In Vitro Cell. Dev. Biol. Anim. 31:14–24.
   PubMedGoogle Scholar
• Hong, E., J. Shin, H. I. Kim, S. T. Lee, and W. Lee. 2004. Solution structure and backbone dynamics of the non-receptor protein-tyrosine kinase-6 Src homology 2 domain. J. Biol. Chem. 279:29700–29708.
   PubMedGoogle Scholar
• Ie Kim, H., and S. T. Lee. 2009. Oncogenic functions of PTK6 are enhanced by its targeting to plasma membrane but abolished by its targeting to nucleus. J. Biochem. 146:133–139.
   PubMed Web of Science ®Google Scholar
• Jacinto, E., V. Facchinetti, D. Liu, N. Soto, S. Wei, S. Y. Jung, Q. Huang, J. Qin, and B. Su. 2006. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127:125–137.
   PubMed Web of Science ®Google Scholar
• Jiang, T., and Y. Qiu. 2003. Interaction between Src and a C-terminal proline-rich motif of Akt is required for Akt activation. J. Biol. Chem. 278:15789–15793.
   PubMedGoogle Scholar
• Jung, H. S., D. W. Kim, Y. S. Jo, H. K. Chung, J. H. Song, J. S. Park, K. C. Park, S. H. Park, J. H. Hwang, K. W. Jo, and M. Shong. 2005. Regulation of protein kinase B tyrosine phosphorylation by thyroid-specific oncogenic RET/PTC kinases. Mol. Endocrinol. 19:2748–2759.
   PubMedGoogle Scholar
• Kamalati, T., H. E. Jolin, M. J. Fry, and M. R. Crompton. 2000. Expression of the BRK tyrosine kinase in mammary epithelial cells enhances the coupling of EGF signalling to PI 3-kinase and Akt, via erbB3 phosphorylation. Oncogene 19:5471–5476.
   PubMed Web of Science ®Google Scholar
• Kamalati, T., H. E. Jolin, P. J. Mitchell, K. T. Barker, L. E. Jackson, C. J. Dean, M. J. Page, B. A. Gusterson, and M. R. Crompton. 1996. Brk, a breast tumor-derived non-receptor protein-tyrosine kinase, sensitizes mammary epithelial cells to epidermal growth factor. J. Biol. Chem. 271:30956–30963.
   PubMed Web of Science ®Google Scholar
• Klinghoffer, R. A., C. Sachsenmaier, J. A. Cooper, and P. Soriano. 1999. Src family kinases are required for integrin but not PDGFR signal transduction. EMBO J. 18:2459–2471.
   PubMed Web of Science ®Google Scholar
• Lee, S. T., K. M. Strunk, and R. A. Spritz. 1993. A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes. Oncogene 8:3403–3410.
   PubMedGoogle Scholar
• Lin, H. S., G. J. Berry, W. E. Fee, Jr., D. J. Terris, and Z. Sun. 2004. Identification of tyrosine kinases overexpressed in head and neck cancer. Arch. Otolaryngol. Head Neck Surg. 130:311–316.
   PubMedGoogle Scholar
• Llor, X., M. S. Serfas, W. Bie, V. Vasioukhin, M. Polonskaia, J. Derry, C. M. Abbott, and A. L. Tyner. 1999. BRK/Sik expression in the gastrointestinal tract and in colon tumors. Clin. Cancer Res. 5:1767–1777.
   PubMed Web of Science ®Google Scholar
• Lodeiro, M., M. Theodoropoulou, M. Pardo, F. F. Casanueva, and J. P. Camina. 2009. c-Src regulates Akt signaling in response to ghrelin via beta-arrestin signaling-independent and -dependent mechanisms. PLoS One 4:e4686.
   PubMedGoogle Scholar
• Lukong, K. E., D. Larocque, A. L. Tyner, and S. Richard. 2005. Tyrosine phosphorylation of sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression. J. Biol. Chem. 280:38639–38647.
   PubMed Web of Science ®Google Scholar
• Mahajan, K., D. Coppola, S. Challa, B. Fang, Y. A. Chen, W. Zhu, A. S. Lopez, J. Koomen, R. W. Engelman, C. Rivera, R. S. Muraoka-Cook, J. Q. Cheng, E. Schonbrunn, S. M. Sebti, H. S. Earp, and N. P. Mahajan. 2010. Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation. PLoS One 5:e9646.
   PubMed Web of Science ®Google Scholar
• Manning, B. D., and L. C. Cantley. 2007. AKT/PKB signaling: navigating downstream. Cell 129:1261–1274.
   PubMed Web of Science ®Google Scholar
• Mitchell, P. J., K. T. Barker, J. E. Martindale, T. Kamalati, P. N. Lowe, M. J. Page, B. A. Gusterson, and M. R. Crompton. 1994. Cloning and characterisation of cDNAs encoding a novel non-receptor tyrosine kinase, brk, expressed in human breast tumours. Oncogene 9:2383–2390.
   PubMed Web of Science ®Google Scholar
• Ostrander, J. H., A. R. Daniel, K. Lofgren, C. G. Kleer, and C. A. Lange. 2007. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells. Cancer Res. 67:4199–4209.
   PubMed Web of Science ®Google Scholar
• Palka-Hamblin, H. L., J. J. Gierut, W. Bie, P. M. Brauer, Y. Zheng, J. M. Asara, and A. L. Tyner. 2010. Identification of β-catenin as a target of the intracellular tyrosine kinase PTK6. J. Cell Sci. 23:236–245.
   Google Scholar
• Petro, B. J., R. C. Tan, A. L. Tyner, M. W. Lingen, and K. Watanabe. 2004. Differential expression of the non-receptor tyrosine kinase BRK in oral squamous cell carcinoma and normal oral epithelium. Oral Oncol. 40:1040–1047.
   PubMed Web of Science ®Google Scholar
• Qiu, H., and W. T. Miller. 2002. Regulation of the nonreceptor tyrosine kinase Brk by autophosphorylation and by autoinhibition. J. Biol. Chem. 277:34634–34641.
   PubMed Web of Science ®Google Scholar
• Qiu, H., and W. T. Miller. 2004. Role of the Brk SH3 domain in substrate recognition. Oncogene 23:2216–2223.
   PubMedGoogle Scholar
• Robey, R. B., and N. Hay. 2009. Is Akt the “Warburg kinase”?—Akt-energy metabolism interactions and oncogenesis. Semin. Cancer Biol. 19:25–31.
   PubMed Web of Science ®Google Scholar
• Sarbassov, D. D., D. A. Guertin, S. M. Ali, and D. M. Sabatini. 2005. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307:1098–1101.
   PubMed Web of Science ®Google Scholar
• Schmandt, R. E., M. Bennett, S. Clifford, A. Thornton, F. Jiang, R. R. Broaddus, C. C. Sun, K. H. Lu, A. K. Sood, and D. M. Gershenson. 2006. The BRK tyrosine kinase is expressed in high-grade serous carcinoma of the ovary. Cancer Biol. Ther. 5:1136–1141.
   PubMed Web of Science ®Google Scholar
• Serfas, M. S., and A. L. Tyner. 2003. Brk, Srm, Frk, and Src42A form a distinct family of intracellular Src-like tyrosine kinases. Oncol. Res. 13:409–419.
   PubMed Web of Science ®Google Scholar
• Shen, C. H., H. Y. Chen, M. S. Lin, F. Y. Li, C. C. Chang, M. L. Kuo, J. Settleman, and R. H. Chen. 2008. Breast tumor kinase phosphorylates p190RhoGAP to regulate rho and ras and promote breast carcinoma growth, migration, and invasion. Cancer Res. 68:7779–7787.
   PubMed Web of Science ®Google Scholar
• Siyanova, E. Y., M. S. Serfas, I. A. Mazo, and A. L. Tyner. 1994. Tyrosine kinase gene expression in the mouse small intestine. Oncogene 9:2053–2057.
   PubMed Web of Science ®Google Scholar
• Vasioukhin, V., M. S. Serfas, E. Y. Siyanova, M. Polonskaia, V. J. Costigan, B. Liu, A. Thomason, and A. L. Tyner. 1995. A novel intracellular epithelial cell tyrosine kinase is expressed in the skin and gastrointestinal tract. Oncogene 10:349–357.
   PubMed Web of Science ®Google Scholar
• Vasioukhin, V., and A. L. Tyner. 1997. A role for the epithelial-cell-specific tyrosine kinase Sik during keratinocyte differentiation. Proc. Natl. Acad. Sci. U. S. A. 94:14477–14482.
   PubMed Web of Science ®Google Scholar
• Wang, T. C., S. H. Jee, T. F. Tsai, Y. L. Huang, W. L. Tsai, and R. H. Chen. 2005. Role of breast tumour kinase in the in vitro differentiation of HaCaT cells. Br. J. Dermatol. 153:282–289.
   PubMed Web of Science ®Google Scholar
• Xiang, B., K. Chatti, H. Qiu, B. Lakshmi, A. Krasnitz, J. Hicks, M. Yu, W. T. Miller, and S. K. Muthuswamy. 2008. Brk is coamplified with ErbB2 to promote proliferation in breast cancer. Proc. Natl. Acad. Sci. U. S. A. 105:12463–12468.
   PubMed Web of Science ®Google Scholar
• Zhang, P., J. H. Ostrander, E. J. Faivre, A. Olsen, D. Fitzsimmons, and C. A. Lange. 2005. Regulated association of protein kinase B/Akt with breast tumor kinase. J. Biol. Chem. 280:1982–1991.
   PubMed Web of Science ®Google Scholar